Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
national blog main
national top stories
3
×
new york blog main
san diego blog main
san francisco blog main
startups
3
×
biotech
boston top stories
boulder/denver blog main
detroit blog main
indiana blog main
life sciences
national
new york top stories
proteon therapeutics
raleigh-durham blog main
san diego top stories
san francisco top stories
seattle blog main
texas blog main
texas top stories
wisconsin blog main
3b pharmaceuticals
abeona therapeutics
acetylon pharmaceuticals
acute myeloid leukemia
adicet bio
aegerion pharmaceuticals
akcea therapeutics
alkermes
allan kaspar
altria
ambys medicines
amgen
amphivena therapeutics
amryt pharma
andrew komjathy
aron knickerbocker
artara therapeutics
What
control
3
×
biotech
according
aiming
akcea
ambys
big
business
cases
centers
cigarettes
comes
company
deadly
deal
deaths
debuted
developing
disease
diseases
effect
electronic
execs
external
factors
formed
founders
future
immigration
including
injuries
innovation
investors
launch
leaders
linked
liver
lung
make
medicines
Language
unset
Current search:
control
×
startups
×
" national top stories "
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
